(1 - 9 von 9
)
Merck acquires OncoEthix
www.biospectrumasia.com
The acquisition expands Merck's oncology portfolio with novel oral BET inhibitor, OTX015
Merck acquires Swiss firm OncoEthix | Pharmafile
www.pharmafile.com
Pharmafile.com is a leading portal for the … industry, providing industry professionals with pharma news, jobs, events, and service company...
OncoEthix In-Licenses OTX015 | Technology Networkswww.technologynetworks.com › news › oncoethix-i...
www.technologynetworks.com
· Dr Kay Noel, Chief Operating Officer who led the licensing effort with Bertrand Damour, Chief Executive Officer, said: “We are excited about the ...
Oncoethix startet Phase-Ib-Studien zu OTX015 im Rahmen der Behandlung...
www.onvista.de
· Bertrand Damour, CEO von Oncoethix, ergänzte: „Wir sind überzeugt, dass OTX015 über das Potenzial verfügt, sich zu einem bedeutenden ...
sortiert nach Relevanz / Datum